Astellas Pharma Inc. (TSE:4503) is seeking acquisitions of companies which can support their activities. Chikashi Takeda, Chief Financial Officer of Astellas Pharma, said, “As this has been mentioned longer time, just a simple size expansion type of M&A is not what we are interested in. As has been conducted Ogeda, Ocata acquisition, and recently, Mitobridge acquisition took place in the Universal. So this time -- so in this way we have focus areas that we would like to do, but still our capability is not sufficient enough. Or we would like to have a company who supports our activities. And if there are technology platform obtained by such companies for that purpose then we would like to consider the opportunity.”